Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm
about
Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.Who Will Use Pre-Exposure Prophylaxis (PrEP) and Why?: Understanding PrEP Awareness and Acceptability amongst Men Who Have Sex with Men in the UK--A Mixed Methods Study.Prioritizing Risk in Preparation for a Demonstration Project: A Mixed Methods Feasibility Study of Oral Pre-Exposure Prophylaxis (PREP) among Female Sex Workers in South IndiaTenofovir-based oral preexposure prophylaxis prevents HIV infection among women.Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study.The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE StudyIntimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study.PrEP implementation research in Africa: what is new?Defining the HIV pre-exposure prophylaxis care continuum.Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants.Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherenceMarkov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis.Delivering PrEP to pregnant and breastfeeding women in sub-Saharan africa: The implementation science frontier.Risk Perception, Sexual Behaviors, and PrEP Adherence Among Substance-Using Men Who Have Sex with Men: a Qualitative Study.Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.Psycho-social Correlates of Condom Use and HIV Testing among MSM Refugees in Beirut, Lebanon.When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling.Alcohol-antiretroviral interactive toxicity beliefs as a potential barrier to HIV pre-exposure prophylaxis among men who have sex with menDaily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelinesPreexposure Prophylaxis and Patient Centeredness: A Call for Holistically Protecting and Promoting the Health of Gay Men.PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.Making an Impact With Preexposure Prophylaxis for Prevention of HIV Infection.Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study.Brief Report: Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa.Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling.Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018.Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes.Pre-exposure Prophylaxis: The Delivery Challenge.
P2860
Q33656112-936BEF9F-0684-4AFB-85A1-2476AF51D494Q35993762-2D5E1136-B288-4648-B118-2A3B0DEC5BE4Q36202628-18A93A00-35AC-45DB-82C5-28AF0A362D1DQ36443803-FB336445-7931-4B61-A65F-B3D20F7F9DFCQ36710299-B0485EE3-0433-4F57-AA95-2A0F2977D8C3Q36988613-7DA2A270-6616-45E6-A0B2-1164797EE832Q36994992-C277B6A3-7047-4CA6-A7F6-84DDE0867013Q37018274-AB90FF4C-1356-40B8-BA02-B575E608DB4EQ37341579-63119AD0-18AC-4053-B87C-2C4DC4A51D04Q37352576-C351A0D6-EE6D-4393-9044-1A9EAE10209FQ37677215-141E4251-EAC9-46D5-B454-239ED21BA359Q38651723-0CE73F61-A2C6-4C43-9E94-CC478BBAA658Q38849535-4F94780F-DE0E-482E-A4BA-C7429FD114D5Q39127005-99142C0F-4D62-4DE3-8733-1932287286F5Q40116624-BB37C8BC-FB9A-4B8A-BEF0-7450758737B9Q40186272-4BA69024-531B-4C1E-8B61-8998C3F54FCBQ40227281-A499736B-E209-459D-BC7A-5BEBE69490D4Q40603253-2CA5157A-52EC-4F99-BD2F-B7A23BABE7A5Q40708259-7588E241-837D-4D83-86D2-C5AE075894B0Q41570992-D9EAE01A-FF4E-401B-AF6E-29CA727E41BFQ41990298-870B2FA4-3AD6-456B-BE6E-986C82747D70Q42334798-D99FD04E-CC7A-4643-87D8-CDE1D4A5DF50Q42390812-2EA0ECED-2540-48E6-A5D7-8F8037686278Q42696079-4364E783-7EF7-40DC-A2F7-A6D25312006FQ45999968-7EC722E0-89CD-4B8F-BB15-D9629061B718Q46103694-DE2E698E-0A79-4B87-A67D-E7ACC92BE8D6Q46479831-B748CCCE-40E7-464B-8CEB-E164D97C86DAQ47398084-20FA5A2D-D0B8-4D21-A541-05AC76A80E49Q48101425-DACC1DD8-5010-4CD1-BF9E-724A40FE0543Q52323543-14ED7D69-789A-439B-AD17-4AE488B8E957Q52571189-A893E0B0-BCF0-415E-AF90-65DB6A4AAB3BQ53429666-B64064A4-6BB0-4A5C-B0D5-8E718A687978Q55299659-425AFD75-0733-4A29-8E2C-81952B2FA8ABQ55715002-76CBF934-7464-4460-A307-2502415ED4E9
P2860
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Defining success with HIV pre- ...... n-effective adherence paradigm
@ast
Defining success with HIV pre- ...... n-effective adherence paradigm
@en
type
label
Defining success with HIV pre- ...... n-effective adherence paradigm
@ast
Defining success with HIV pre- ...... n-effective adherence paradigm
@en
prefLabel
Defining success with HIV pre- ...... n-effective adherence paradigm
@ast
Defining success with HIV pre- ...... n-effective adherence paradigm
@en
P2093
P2860
P1433
P1476
Defining success with HIV pre- ...... n-effective adherence paradigm
@en
P2093
Florence Koechlin
Francois Venter
Jared M Baeten
Jessica E Haberer
K Rivet Amico
Kathryn Curran
Kevin O'Reilly
Nelly Mugo
Pedro Goicochea
Peter Anderson
P2860
P304
P356
10.1097/QAD.0000000000000647
P407
P577
2015-07-01T00:00:00Z